Published in Chest on April 01, 1993
Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev (1996) 10.34
The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev (2010) 4.22
Infection control in cystic fibrosis. Clin Microbiol Rev (2004) 2.45
Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23
Mycobacterium abscessus and children with cystic fibrosis. Emerg Infect Dis (2003) 2.19
Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in france. J Clin Microbiol (2009) 2.03
Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. J Clin Microbiol (2005) 1.83
Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis. J Clin Microbiol (2001) 1.83
Multicenter cross-sectional study of nontuberculous mycobacterial infections among cystic fibrosis patients, Israel. Emerg Infect Dis (2008) 1.76
Recovery of mycobacteria from patients with cystic fibrosis. J Clin Microbiol (1999) 1.37
Inherited and acquired immunodeficiencies underlying tuberculosis in childhood. Immunol Rev (2015) 1.29
Evaluation of BACTEC MGIT 960 and BACTEC 460TB systems for recovery of mycobacteria from clinical specimens of a university hospital with low incidence of tuberculosis. J Clin Microbiol (2001) 1.27
Non-tuberculous mycobacteria in cystic fibrosis. Thorax (1998) 1.20
Clinical significance of a first positive nontuberculous mycobacteria culture in cystic fibrosis. Ann Am Thorac Soc (2014) 0.94
Shifting paradigms of nontuberculous mycobacteria in cystic fibrosis. Respir Res (2014) 0.85
Sampling and decontamination method for culture of nontuberculous mycobacteria in respiratory samples of cystic fibrosis patients. J Clin Microbiol (2013) 0.83
Prospective study on nontuberculous mycobacteria in patients with and without cystic fibrosis. Med Microbiol Immunol (2003) 0.78
Enterovirus concentration on cellulose membranes. Appl Microbiol (1972) 11.78
Concentration of enteroviruses from large volumes of water. Appl Microbiol (1973) 11.43
Concentration of enteroviruses on membrane filters. J Virol (1967) 9.95
Concentration of viruses from sewage by adsorption on millipore membranes. Bull World Health Organ (1967) 7.73
Concentration of viruses from large volumes of tap water using pleated membrane filters. Appl Environ Microbiol (1976) 6.36
Effects of the RAD52 Gene on Recombination in SACCHAROMYCES CEREVISIAE. Genetics (1980) 6.07
Concentration and purification of viruses by adsorption to and elution from insoluble polyelectrolytes. Appl Microbiol (1971) 5.71
Risk adjustment of the postoperative mortality rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg (1997) 4.55
Rapid isolation of bacteria from septicemic patients by use of an antimicrobial agent removal device. J Clin Microbiol (1980) 4.52
Virus aggregation as the cause of the non-neutralizable persistent fraction. J Virol (1967) 4.25
Preparation of antiserum to enteroviruses in large animals. J Immunol (1965) 4.20
Concentration of viruses on aluminum and calcium salts. Am J Epidemiol (1967) 4.19
Concentration of viruses from sewage and excreta on insoluble polyelectrolytes. Appl Microbiol (1969) 4.17
Informed consent for population-based research involving genetics. JAMA (2001) 4.10
Gestational diabetes mellitus--management guidelines. The Australasian Diabetes in Pregnancy Society. Med J Aust (1998) 4.05
Concentration of enteroviruses from large volumes of tap water, treated sewage, and seawater. Appl Environ Microbiol (1978) 4.01
Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J Am Coll Surg (1997) 3.46
Research ethics. Research practice and participant preferences: the growing gulf. Science (2011) 3.27
Virus isolations from sewage and from a stream receiving effluents of sewage treatment plants. Bull World Health Organ (1970) 3.27
Virus and bacteria removal from wastewater by land treatment. Appl Environ Microbiol (1976) 3.10
Environmental factors influencing isolation of enteroviruses from polluted surface waters. Appl Microbiol (1974) 3.06
Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol (1994) 2.92
Gender gap in cystic fibrosis mortality. Am J Epidemiol (1997) 2.74
Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol (1999) 2.73
Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer. Lancet (1999) 2.71
5-Hydroxytryptamine stimulates inositol phosphate production in a cell-free system from blowfly salivary glands. Evidence for a role of GTP in coupling receptor activation to phosphoinositide breakdown. J Biol Chem (1985) 2.60
Colorimetric method for rapid determination of bacteriuria. J Clin Microbiol (1981) 2.51
Enhanced detection of Australia antigen in serum hepatitis patients by discontinuous counter-immunoelectrophoresis. Appl Microbiol (1971) 2.44
Wastewater renovation and reuse: virus removal by soil filtration. Science (1976) 2.37
The complexities of predictive genetic testing. BMJ (2001) 2.36
Effects of pancreatin on the growth of reovirus. J Bacteriol (1966) 2.35
Comparative aspects of primary structures of proteins. Annu Rev Biochem (1968) 2.31
Turning interns into senior residents: preparing residents for their teaching and leadership roles. Acad Med (1995) 2.31
Survey of plasmids and resistance factors in Campylobacter jejuni and Campylobacter coli. Antimicrob Agents Chemother (1985) 2.27
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet (2000) 2.26
Monoclonal antibodies to human estrogen receptor. Proc Natl Acad Sci U S A (1980) 2.24
HFE gene and hereditary hemochromatosis: a HuGE review. Human Genome Epidemiology. Am J Epidemiol (2001) 2.24
Concentration of enteroviruses from estuarine water. Appl Environ Microbiol (1977) 2.22
Concentration and purification of influenza virus on insoluble polyelectrolytes. Appl Microbiol (1972) 2.20
Heavy metal tolerance in the fission yeast requires an ATP-binding cassette-type vacuolar membrane transporter. EMBO J (1992) 2.19
Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax (2002) 2.17
Viruses in water. Bull World Health Organ (1978) 2.10
Propofol 2% in critically ill patients: effect on lipids. Crit Care Med (1997) 2.07
Primary care physicians' knowledge of and experience with pharmacogenetic testing. Clin Genet (2012) 2.07
Reconcentration of poliovirus from sewage. Appl Environ Microbiol (1976) 2.05
Mechanism of enhancement of virus plaques by cationic polymers. J Virol (1968) 2.02
Inactivation of clay-associated bacteriophage MS-2 by chlorine. Appl Environ Microbiol (1977) 2.00
Relation of surgical volume to outcome in eight common operations: results from the VA National Surgical Quality Improvement Program. Ann Surg (1999) 1.98
Concentration of viruses from water by membrane chromatography. Annu Rev Microbiol (1979) 1.94
Probe directed at a segment of Rickettsia rickettsii rRNA amplified with polymerase chain reaction. J Clin Microbiol (1989) 1.91
Why do patients default from follow-up at a genitourinary clinic?: a multivariate analysis. Genitourin Med (1995) 1.86
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85
Microbiological hazards of household toilets: droplet production and the fate of residual organisms. Appl Microbiol (1975) 1.84
Defining a pulmonary exacerbation in cystic fibrosis. J Pediatr (2001) 1.83
Efficient filtration and sizing of viruses with membrane filters. J Virol (1968) 1.81
Photodynamic inactivation of animal viruses: a review. Photochem Photobiol (1966) 1.80
Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors. Pediatrics (1998) 1.80
Detection of 31P nuclear magnetic resonance signals in brain by in vivo and freeze-trapped assays. Proc Natl Acad Sci U S A (1978) 1.78
Proinsulin and the biosynthesis of insulin. Recent Prog Horm Res (1969) 1.78
Current status of long term ventilation of children in the United Kingdom: questionnaire survey. BMJ (1999) 1.73
Airway function in infants newly diagnosed with cystic fibrosis. Lancet (2001) 1.72
Plaque enhancement of enteroviruses by magnesium chloride, cysteine, and pancreatin. J Bacteriol (1966) 1.70
Development of a simple method for concentrating enteroviruses from oysters. Appl Microbiol (1975) 1.69
Lymphocytosis of gamma/delta T cells in human ehrlichiosis. Am J Clin Pathol (1995) 1.68
Impact of HIV infection on the development, clinical presentation, and outcome of tuberculosis among children in Abidjan, Côte d'Ivoire. AIDS (1997) 1.63
Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis. Am Rev Respir Dis (1993) 1.63
Persistent Campylobacter jejuni infection in an immunocompromised patient. Ann Intern Med (1984) 1.62
Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection. JAMA (1999) 1.61
Comparison of surgical outcomes between teaching and nonteaching hospitals in the Department of Veterans Affairs. Ann Surg (2001) 1.61
A simple method for concentration of enteroviruses and rotaviruses from cell culture harvests using membrane filters. Intervirology (1978) 1.58
Thermostabilization and thermosensitization of herpesvirus. J Bacteriol (1965) 1.57
Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients. Am J Hum Genet (1994) 1.56
Serum and lower respiratory tract drug concentrations after tobramycin inhalation in young children with cystic fibrosis. J Pediatr (2001) 1.56
What internists need to know: core competencies in women's health. ABIM Subcommittee on Clinical Competence in Women's Health. Am J Med (1997) 1.55
Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Thorax (2002) 1.54
Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. Am J Epidemiol (2008) 1.53
Review of wheat improvement for waterlogging tolerance in Australia and India: the importance of anaerobiosis and element toxicities associated with different soils. Ann Bot (2008) 1.53
Increase in desipramine serum levels associated with methadone treatment. Am J Psychiatry (1989) 1.53
Photodynamic treatment of herpes keratitis. Infect Immun (1972) 1.51
Estrogen and progesterone receptors in the normal female breast. Cancer Res (1991) 1.50
Translation of satellite tobacco necrosis virus ribonucleic acid. I. Characterization of in vitro procaryotic and eucaryotic translation products. Biochemistry (1972) 1.50
Concentration of enteroviruses from large volumes of turbid estuary water. Can J Microbiol (1977) 1.49
Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev (1999) 1.49
Peripheral aneurysms and arteriomegaly: is there a familial pattern? J Vasc Surg (1998) 1.47
Primary care internal medicine: a challenging career choice for the 1990s. Ann Intern Med (1990) 1.45
A decade's experience with quality improvement in cardiac surgery using the Veterans Affairs and Society of Thoracic Surgeons national databases. Ann Surg (2001) 1.45
Specialized intestinal metaplasia in patients with gastro-oesophageal reflux disease. Br J Surg (2000) 1.44
Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis. J Pediatr (1988) 1.44
Stabilization of enveloped viruses by dimethyl sulfoxide. J Virol (1968) 1.44
Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis. A phase 1 study. JAMA (1992) 1.43
Home nebulizer use among patients with cystic fibrosis. J Pediatr (1998) 1.41
If you care about women's health, perhaps you should care about the risks of direct marketing of tamoxifen to consumers. Eff Clin Pract (2000) 1.39
The advent of the "unpatients'. Nat Med (1996) 1.36
Ancillary risk information and pharmacogenetic tests: social and policy implications. Pharmacogenomics J (2007) 1.34
Primary structure of the cytochrome c from the great grey kangaroo, Macropus canguru. J Biol Chem (1966) 1.33
Disuse in the lateral geniculate nucleus of the cat. J Physiol (1968) 1.33
Utilization of salivary concentrations of ciprofloxacin in subjects with cystic fibrosis. Infection (1997) 1.32
Herpes genitalis treated by photodynamic inactivation of virus. Am J Obstet Gynecol (1973) 1.32